pubmed-article:8651781 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8651781 | lifeskim:mentions | umls-concept:C0032824 | lld:lifeskim |
pubmed-article:8651781 | lifeskim:mentions | umls-concept:C0018791 | lld:lifeskim |
pubmed-article:8651781 | lifeskim:mentions | umls-concept:C0376315 | lld:lifeskim |
pubmed-article:8651781 | lifeskim:mentions | umls-concept:C1704419 | lld:lifeskim |
pubmed-article:8651781 | lifeskim:mentions | umls-concept:C1882151 | lld:lifeskim |
pubmed-article:8651781 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:8651781 | pubmed:dateCreated | 1996-7-22 | lld:pubmed |
pubmed-article:8651781 | pubmed:abstractText | Opening of adenosine triphosphate-sensitive potassium channels might be one of the mechanisms by which preconditioning preserves the myocardium against ischemic damage. The present study was therefore designed to compare the protective efficacy of ischemic preconditioning with that of pharmacologic preconditioning involving the use of a potassium channel opener in a surgically relevant model of cold cardioplegic arrest. | lld:pubmed |
pubmed-article:8651781 | pubmed:language | eng | lld:pubmed |
pubmed-article:8651781 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8651781 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:8651781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8651781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8651781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8651781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8651781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8651781 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8651781 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8651781 | pubmed:month | Jun | lld:pubmed |
pubmed-article:8651781 | pubmed:issn | 0003-4975 | lld:pubmed |
pubmed-article:8651781 | pubmed:author | pubmed-author:GroussetCC | lld:pubmed |
pubmed-article:8651781 | pubmed:author | pubmed-author:MouasCC | lld:pubmed |
pubmed-article:8651781 | pubmed:author | pubmed-author:MenaschéPP | lld:pubmed |
pubmed-article:8651781 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8651781 | pubmed:volume | 61 | lld:pubmed |
pubmed-article:8651781 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8651781 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8651781 | pubmed:pagination | 1764-8 | lld:pubmed |
pubmed-article:8651781 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:meshHeading | pubmed-meshheading:8651781-... | lld:pubmed |
pubmed-article:8651781 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8651781 | pubmed:articleTitle | Is potassium channel opening an effective form of preconditioning before cardioplegia? | lld:pubmed |
pubmed-article:8651781 | pubmed:affiliation | Department of Cardiovascular Surgery, Hôpital Lariboisière, Paris, France. | lld:pubmed |
pubmed-article:8651781 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8651781 | pubmed:publicationType | Comparative Study | lld:pubmed |